Skip to main content

Table 3 Sample Characteristics

From: Cost and outcomes of routine HIV care and treatment: public and private service delivery models covering low-income earners in South Africa

 

Total

 

Pub1

 

Pub2

 

Prv1 (NGO)

 

Prv2 (GP)

 

Prv3 (Nurse)

 
 

N=376

 

n=76

 

n=75

 

n=75

 

n=75

 

n=75

 

Gender, n(%)

Male

177

(47%)

17

(22%)

21

(28%)

29

(39%)

35

(47%)

12

(16%)

Female

199

(53%)

59

(78%)

54

(72%)

46

(61%)

40

(53%)

63

(84%)

Age, n(%)

18-30

111

(30%)

30

(39%)

24

(32%)

22

(29%)

17

(23%)

18

(24%)

31-40

151

(40%)

29

(38%)

24

(32%)

35

(47%)

27

(36%)

36

(48%)

41-50

77

(20%)

13

(17%)

16

(21%)

14

(19%)

19

(25%)

15

(20%)

>50

37

(10%)

4

(5%)

11

(15%)

4

(5%)

12

(16%)

6

(8%)

Age, median (IQR)

34

(29.0-42.0)

31.5

(27.0-37.5)

36

(29.0-45.0)

34

(30.0-35.0)

38

(27.0-29.0)

34

(30.0-40.0)

Baseline ART regimen, n (%)

Fixed dose combination (TDF-FTC-EFV)

372

(99%)

75

(99%)

72

(96%)

75

(100%)

75

(100%)

75

(100%)

ABC-3TC-EFV

4

(1%)

1

(1%)

3

(4%)

0

(%)

0

(%)

0

(%)

Baseline CD4 count, n (%)

 

<100 cells/mm3

42

(11%)

5

(7%)

14

(19%)

16

(21%)

7

(9%)

-

 

101-200 cells/mm3

38

(10%)

5

(7%)

9

(12%)

10

(13%)

14

(19%)

-

 

201-350 cells/mm3

73

(19%)

22

(29%)

14

(19%)

22

(29%)

15

(20%)

-

 

>351 cells/mm3

124

(33%)

34

(45%)

29

(39%)

23

(31%)

38

(51%)

-

 

Missing

99

(26%)

10

(13%)

9

(12%)

4

(5%)

1

(1%)

75

(100%)

Baseline CD4 count, median (IQR)

330

(166-509)

372

(272-496)

327

(116-513)

246

(115-410)

369

(191-664)

-

 

ART naïve at enrolment, n (%)

293

(97%)

73

(96%)

71

(95%)

74

(99%)

75

(100%)

not reported

Mean days on ART at enrolment, if not ART naïve

426

38

817

24

-

 

not reported

Mean number of comorbidities

0.13

0.14

0.12

0.24

not reported

0.03